Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation.
Metadata only so far. Questions are answered only with quotes from this document. Source: europepmc, retrieved 2026-11-02.
Record metadata
- Journal
- Am J Cancer Res
- Date
- 2024-09-15
- Citations
- 6
Not in the data yet: a study card. Cards (population, design, endpoints, result direction, each tied to a quote) arrive with the knowledge layer’s card lane. The fields above are registry or bibliographic metadata, not quotes.
Ask this document
Answers come only from this document’s licensed passages, as highlighted quotes. If it doesn’t say, you get that instead of a guess.
Source text
No passages are loaded for this document yet.